Clinical trials sponsored by UNC Lineberger Comprehensive Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by UNC Lineberger Comprehensive Cancer Center

• Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
  NCT07463833 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
  NCT05620342 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Autologous CAR-T Cells Targeting B7-H3 in PDAC
  NCT06158139 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• BREAST Choice Decision Tool R21 - AIM2
  NCT06817226 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
  NCT06483555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
  NCT07428330 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 49 Years · Sex: Female · 1 location
• Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
  NCT05472792 · Phase: Phase 2 · Ages: 65 Years and older · Sex: Female · 1 location
• Designing Visual Tools to Enhance Cancer Surgeon Decision-making
  NCT06965192 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Dissemination of BREASTChoice AIM1-B
  NCT07396766 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Evaluation of Child Care Staff Weight Management Program
  NCT05656807 · Phase: Not applicable (e.g. observational or device study) · Ages: 2 Years and older · Sex: All (male and female) · 1 location
• Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
  NCT05440929 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
  NCT07340541 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
  NCT07313306 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
  NCT03769415 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome
  NCT07296861 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
  NCT07025785 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Nutrition Awareness Among Women With Non-Metastatic Breast Cancer
  NCT07389967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
  NCT05542407 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 1 location
• PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
  NCT07069595 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
  NCT06896162 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
  NCT07276880 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Promoting CT Engagement for Pancreatic Cancer With App
  NCT06252545 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
  NCT06347068 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Trilaciclib and Lurbinectidin
  NCT05578326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Tirzepatide in Obesity-Driven Endometrial Cancer
  NCT07065552 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Female · 1 location
• Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
  NCT07225114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• UNC Pleural Fluid Registry
  NCT05620329 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
  NCT03454035 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
  NCT06902311 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 1 location
• Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa
  NCT05413798 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years and older · Sex: Female · 1 location
• Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
  NCT06848491 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 39 Years · Sex: All (male and female) · 1 location
• VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients
  NCT06878547 · Phase: Not specified · Ages: 20 Years to 90 Years · Sex: Female · 1 location

Common questions

How many trials is UNC Lineberger Comprehensive Cancer Center recruiting for?

UNC Lineberger Comprehensive Cancer Center is the lead sponsor of 32 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.